ArticleJournal of translational medicine2022

Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.

John D Karalis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.